A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell ...

A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem ...

Rice University's Han Xiao has used his AI-supported Sequence Display technology to expand the targeting abilities of ...

Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and ...

NEW ORLEANS, LA—An investigational CRISPR-Cas9 gene-editing therapy that targets angiopoietin-like protein 3 (ANGPTL3), which has a role in regulating lipid metabolism, appears to safely lower levels ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Despite this advance, conventional CRISPR-Cas9 systems may introduce potentially harmful DNA breaks and cannot easily be ...

CRISPR Therapeutics (NasdaqGM:CRSP) appointed Siva Sakhamuri, Ph.D., as Chief Technical Officer, according to a recent ...

Targeting CRISPR–Cas9 at centromeric retrotransposons in hexaploid bread wheat reconfigured up to 11 chromosomes in a single ...